4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-020376
Director sold 9,000 shares at an average $20.29 ($182,636)
- Director acquired 9,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guiheen Lawrence P. Director | 2025-05-21 | Option exercise | +7,779 | $5.96 | $46,363 | 122,609 | D: show line 1 in the form |
| Guiheen Lawrence P. Director | 2025-05-21 | Sale | −7,779 | $20.32 | $158,069 | 114,830 | D: show line 2 in the form |
| Guiheen Lawrence P. Director | 2025-05-22 | Option exercise | +1,221 | $5.96 | $7,277 | 116,051 | D: show line 3 in the form |
| Guiheen Lawrence P. Director | 2025-05-22 | Sale | −1,221 | $20.12 | $24,567 | 114,830 | D: show line 4 in the form |
| Open-market sales · 9,000 sh · avg $20.29 · $182,636 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guiheen Lawrence P. Director | 2025-05-21 | Option exercise · Stock Option (right to buy) | −7,779 | 1,221 | D: show line 5 in the form | ||
| Guiheen Lawrence P. Director | 2025-05-22 | Option exercise · Stock Option (right to buy) | −1,221 | 0 | D: show line 6 in the form |
Loading xslF345X05/form4.xml…